Nesher Technologies, Inc.
Nanobiotech for smarter diagnostics and cutting-edge biomedical research

01 May 2012

NTI receives SBIR grant funding from the NIH/National Cancer Institute (NCI) to develop a multiplexed assay for lung cancer-specific microRNA detection.
FacebookTwitterDiggStumbleuponTechnoratiLinkedin